Showing results (561-570 of 594) with videos related to
Sort By:
Pageof 60
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Preclinical studies on LY228729: a potent and selective serotonin1A agonistM M Foreman, R W Fuller, J D Leander, et al.Journal of Medical Genetics|February 1, 1993
The fragile X syndrome: no evidence for any recent mutationsA P Smits, J C Dreesen, J G Post, et al.Cell Reports|November 1, 2018
N6-Methyladenosine Inhibits Local Ribonucleolytic Cleavage to Stabilize mRNAs in ArabidopsisStephen J Anderson, Marianne C Kramer, Sager J Gosai, et al.Life Sciences|January 1, 1997
Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraineL A Phebus, K W Johnson, J M Zgombick, et al.Plant Biotechnology Journal|July 20, 2024
Regulation of a single inositol 1-phosphate synthase homeologue by HSFA6B contributes to fibre yield maintenance under drought conditions in upland cottonLi'ang Yu, Anna C Nelson Dittrich, Xiaodan Zhang, et al.Journal of Thrombosis and Haemostasis : JTH|July 15, 2006
Genetic determinants of normal variation in coagulation factor (F) IX levels: genome-wide scan and examination of the FIX structural geneM Khachidze, A Buil, K R Viel, et al.Human Molecular Genetics|October 1, 1995
An integrated physical and genetic map of a 35 Mb region on chromosome Xp22.3-Xp21.3G B Ferrero, B Franco, E J Roth, et al.European Journal of Pharmacology|December 6, 2001
In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist propertiesI A Pullar, J R Boot, S L Carney, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 1999
Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distributionJ A Carrasquillo, J D White, C H Paik, et al.Proceedings of the National Academy of Sciences of the United States of America|November 29, 2001
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's diseaseY Du, Z Ma, S Lin, et al.Pageof 60